Study to Determine the Pharmacokinetics, Safety & Tolerability of Aripiprazole in Adults With Schizophrenia
Clinical trial NCT03150771 · COMPLETED
Trial details
- NCT number
- NCT03150771
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-14
- Primary completion
- 2018-04-18
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.